NCT06107452 Customization of Cardiac Readaptation Based on Force-velocity Profile and Heart Rate Variability
| NCT ID | NCT06107452 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Acute Coronary Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2024-02-05 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2024-02-05 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiac readaptation aims to mitigate cardiovascular risks and enhance the quality of life among coronary patients. Our research laboratory has an international expertise in training optimization in top-athletes and a previous study has demonstrated the efficacy of optimizing cardiac rehabilitation through the power-force-velocity profile (PFVP). The findings exhibited significant improvements in aerobic capacity, muscular strength, and cardiovascular parameters among patients who were trained based on their PFVP. Guided training utilizing heart rate variability (HRV) is also garnering increasing interest as a means to optimize training load and promote recovery
Eligibility Criteria
Inclusion Criteria: * \>18 * Acute Coronary Syndrome treated in the last 6 months * Medical revascularization (angioplasty ± stenting) or surgical (coronary artery bypass) * Initial CPETt: MPA ≥ 60w in women and ≥80w in men * French * Informed consent Exclusion Criteria: \- Significant co-morbidities limited practice of physical activity
Contact & Investigator
David HUPIN, MD
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Saint Etienne
Frequently Asked Questions
Who can join the NCT06107452 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06107452 currently recruiting?
Yes, NCT06107452 is actively recruiting participants. Contact the research team at David.Hupin@chu-st-etienne.fr for enrollment information.
Where is the NCT06107452 trial being conducted?
This trial is being conducted at Saint-Etienne, France.
Who is sponsoring the NCT06107452 clinical trial?
NCT06107452 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is David HUPIN, MD at Centre Hospitalier Universitaire de Saint Etienne. The trial plans to enroll 110 participants.